Response of community pharmacists to the presentation of back pain: A simulated patient study

International Journal of Pharmacy Practice

Volumn 14, Issue 3, 2006, Pages 171-178

  Chua, Siew Siang ^a   Ramachandran, Claire Devi ^a   Paraidathathu, Thomas T ^b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DICLOFENAC POTASSIUM; IBUPROFEN; KETOPROFEN; MEFENAMIC ACID; MELOXICAM; MUSCLE RELAXANT AGENT; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; NORGESIC; ROFECOXIB; SALICYLIC ACID METHYL ESTER; VITAMIN B COMPLEX;

ADULT; AGED; ARTICLE; BACKACHE; CONSULTATION; CONTROLLED STUDY; DROWSINESS; DRUG COST; DRUG HYPERSENSITIVITY; FEMALE; GASTROINTESTINAL SYMPTOM; HEALTH SERVICES RESEARCH; HUMAN; HUMAN EXPERIMENT; MALAYSIA; MALE; MEDICAL INFORMATION; PATIENT COUNSELING; PATIENT INFORMATION; PATIENT SATISFACTION; PHARMACIST; PHARMACY; PRIORITY JOURNAL; PROFESSIONAL PRACTICE;

EID: 33748567104     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/ijpp.14.3.0003     Document Type: Article

References (33)

1. Taylor J. OTC counseling: review of pharmacists performance. Medscape Pharmacists 2001;2(2). www.medscape.com/viewarticle/408580 (accessed April 24, 2006).
2. Blenkinsopp A, Bradley C. Patients, society, and the increase in self medication. BMJ 1996;312:629-32.
3. Sierralta OE, Scott DM. Pharmacists as nonprescription drug advisors. Am Pharm 1995;NS35:36-8.
4. Whitehead P, Atkin P, Krass I, Benrimoj SI. Patient drug information and consumer choice of pharmacy. Int J Pharm Pract 1999;7:71-9.
5. Allan EL, Barker KN, Malloy MJ, Heller WM. Dispensing errors and counselling in community practice. Am Pharm 1995;NS35:25-33.
6. Anonymous. Only 4 of 10 patients report receiving pharmacist counseling on outpatient prescriptions. Am J Hosp Pharm 1994;51:3020.
7. Anonymous. ASHP guidelines on pharmacist-conducted patient education and counseling. Am J Health-Syst Pharm 1997;54:431-4.
8. Aslanpour Z, Smith FJ. Oral counselling on dispensed medication: survey of its extent and associated factors in a random sample of community pharmacies. Int J Pharm Pract 1997;5:57-63.
9. Raisch DW. Patient counseling in community pharmacy and its relationship with prescription payment methods and practice settings. Ann Pharmacother 1993;27:1173-9.
10. Kirking DM. Evaluation of an explanatory model of pharmacists' patient counseling activities. J Soc Admin Pharm 1984;2(2):50-6.
11. Goel PK, Ross-Degnan D, McLaughlin TJ, Soumerai SB. Influence of location and staff knowledge on quality of retail pharmacy prescribing for childhood diarrhea in Kenya. Int J Qual Health Care 1996;8:519-62.
12. Norris P. Which sorts of pharmacies provide more patient counseling. J Health Serv Res Policy 2002;7 (suppl):23-8.
13. Chua SS, Cheong NK, Teh LK. Utilization of community pharmacists by the general public in the Klang Valley. FAPA 2002 Abstract. The 19th Congress of FAPA: Asian Congress of Pharmaceutical Science and Practice, Seoul, Korea, 5-8 October 2002.
14. 2-receptor antagonists and alginate products from pharmacies. Int J Pharm Pract 2003;11:33-9.
15. Schommer JC, Wiederholt JB. Pharmacists' views of patient counseling. Am Pharm 1994;NS34:46-53.
16. Schommer JC, Wiederholt JB. Pharmacists' perceptions of patients' needs for counseling. Am J Hosp Pharm 1994;51:478-85.
17. Vainio KK, Airaksinen MS, Hyykky TT, Enlund KH. Effect of therapeutic class on counseling in community pharmacies. Ann Pharmacother 2002;36:781-6.
18. Ortiz M, Walker WL, Thomas R. Comparisons between methods of assessing patient counselling in Australian community pharmacies. J Soc Admin Pharm 1989;6:39-48.
19. Roper Starch Worldwide. Consumer survey on self-medication. Washington DC: Consumer Health Care Products Association; 2001.
20. BMRB everyday healthcare study of self-medication in Great Britain, London: British Market Research Bureau International; 1997.
21. Blenkinsopp A, Paxton P. Symptoms in the pharmacy. A guide to the management of common illness. Oxford: Blackwell Scientific Publications; 1992. pp 143-9.
22. Fraser WR. Back pain. Medicine Consumer Health, emedicine.com, Inc; 2003. www.emedicinehealth.com/fulltext/4563.htm (accessed April 24, 2006).
23. Abramson JH, Abramson ZH. Survey methods in community medicine. Edinburgh: Churchill Livingstone; 1999. p 407.
24. Kennedy EJ. Responding to symptoms. In: Winfield AJ, Richards RME, editors. Pharmaceutical practice, 2nd edn. Edinburgh: Churchill Livingstone; 1998. pp 366-79.
25. Anonymous. ASHP guidelines on pharmacist-conducted patient counselling. Am J Hosp Pharm 1993;50:505-6.
26. Rumore MM, Feifer S, Rumore JS. New York city pharmacists and OBRA '90: one year later. Am Pharm 1995;NS35:29-34,66.
27. Sclar DA, Robison LM, Skaer TL, Over-the-counter Medication Intervention Project Team. Pharmacy consultation and over-the-counter medication purchasing outcomes. J Clin Pharm Ther 1996;21:177-84.
28. Peterson GM. Selecting nonprescription analgesics. Am J Ther 2005;12:67-79.
29. Rives PA, Douglas AB. Evaluation and treatment of low back pain in family practice. J Am Board Fam Pract 2004;17:S23-31.
30. Chua SS, Paraidathathu T. Utilisation of non-steroidal anti-inflammatory drugs (NSAIDs) through community pharmacies in Malaysia. Asia Pac J Public Health 2005;17:117-23.
31. McManus P, Primrose JG, Henry DA, Birkett DJ, Lindner J, Day RO. Pattern of non-steroidal anti-inflammatory drug use in Australia 1990-1994. A report from the Drug Utilization Sub-Committee of the Pharmaceutical Benefits Advisory Committee. Med J Aust 1996;164:589-92.
32. Henry D, Lim LL-Y, Garcia Rodriguez LA et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 1996;312:1563-6.
33. FitzGerald GA. Coxibs and cardiovascular disease. N Engl J Med 2004;351:1709-11.